161 related articles for article (PubMed ID: 34295225)
21. Genetic animal models of malformations of cortical development and epilepsy.
Wong M; Roper SN
J Neurosci Methods; 2016 Feb; 260():73-82. PubMed ID: 25911067
[TBL] [Abstract][Full Text] [Related]
22. GATOR1-related focal cortical dysplasia in epilepsy surgery patients and their families: A possible gradient in severity?
Benova B; Sanders MWCB; Uhrova-Meszarosova A; Belohlavkova A; Hermanovska B; Novak V; Stanek D; Vlckova M; Zamecnik J; Aronica E; Braun KPJ; Koeleman BPC; Jansen FE; Krsek P
Eur J Paediatr Neurol; 2021 Jan; 30():88-96. PubMed ID: 33461085
[TBL] [Abstract][Full Text] [Related]
23. Infantile tauopathies: Hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma.
Sarnat HB; Flores-Sarnat L
Brain Dev; 2015 Jun; 37(6):553-62. PubMed ID: 25451314
[TBL] [Abstract][Full Text] [Related]
24. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.
Lim JS; Gopalappa R; Kim SH; Ramakrishna S; Lee M; Kim WI; Kim J; Park SM; Lee J; Oh JH; Kim HD; Park CH; Lee JS; Kim S; Kim DS; Han JM; Kang HC; Kim HH; Lee JH
Am J Hum Genet; 2017 Mar; 100(3):454-472. PubMed ID: 28215400
[TBL] [Abstract][Full Text] [Related]
25. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
Lim JS; Kim WI; Kang HC; Kim SH; Park AH; Park EK; Cho YW; Kim S; Kim HM; Kim JA; Kim J; Rhee H; Kang SG; Kim HD; Kim D; Kim DS; Lee JH
Nat Med; 2015 Apr; 21(4):395-400. PubMed ID: 25799227
[TBL] [Abstract][Full Text] [Related]
26. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
[TBL] [Abstract][Full Text] [Related]
27. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.
Yasin SA; Ali AM; Tata M; Picker SR; Anderson GW; Latimer-Bowman E; Nicholson SL; Harkness W; Cross JH; Paine SM; Jacques TS
Acta Neuropathol; 2013 Aug; 126(2):207-18. PubMed ID: 23728790
[TBL] [Abstract][Full Text] [Related]
28. Brain somatic mutations in MTOR leading to focal cortical dysplasia.
Lim JS; Lee JH
BMB Rep; 2016 Feb; 49(2):71-2. PubMed ID: 26779999
[TBL] [Abstract][Full Text] [Related]
29. Expression of the Nogo-A system in cortical lesions of pediatric patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
Yu SX; Li S; Shu HF; Zhang CQ; Liu SY; Yang H
J Neuropathol Exp Neurol; 2012 Jul; 71(7):665-77. PubMed ID: 22710967
[TBL] [Abstract][Full Text] [Related]
30. The Putative Role of mTOR Inhibitors in Non-tuberous Sclerosis Complex-Related Epilepsy.
Goldstein HE; Hauptman JS
Front Neurol; 2021; 12():639319. PubMed ID: 33643212
[TBL] [Abstract][Full Text] [Related]
31. Tuberous sclerosis complex as a model disease for developing new therapeutics for epilepsy.
Jeong A; Wong M
Expert Rev Neurother; 2016; 16(4):437-47. PubMed ID: 26854692
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Sun FJ; Zhang CQ; Chen X; Wei YJ; Li S; Liu SY; Zang ZL; He JJ; Guo W; Yang H
J Neuroinflammation; 2016 Apr; 13(1):85. PubMed ID: 27095555
[TBL] [Abstract][Full Text] [Related]
33. Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.
Patil VV; Guzman M; Carter AN; Rathore G; Yoshor D; Curry D; Wilfong A; Agadi S; Swann JW; Adesina AM; Bhattacharjee MB; Anderson AE
Neuropathology; 2016 Apr; 36(2):146-56. PubMed ID: 26381727
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Li S; Yu S; Zhang C; Shu H; Liu S; An N; Yang M; Yin Q; Yang H
Brain Res; 2012 May; 1453():46-55. PubMed ID: 22459050
[TBL] [Abstract][Full Text] [Related]
35. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study.
Baldassari S; Ribierre T; Marsan E; Adle-Biassette H; Ferrand-Sorbets S; Bulteau C; Dorison N; Fohlen M; Polivka M; Weckhuysen S; Dorfmüller G; Chipaux M; Baulac S
Acta Neuropathol; 2019 Dec; 138(6):885-900. PubMed ID: 31444548
[TBL] [Abstract][Full Text] [Related]
36. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex.
Zhang B; Zou J; Han L; Beeler B; Friedman JL; Griffin E; Piao YS; Rensing NR; Wong M
Epilepsia; 2018 Sep; 59(9):1796-1806. PubMed ID: 30079598
[TBL] [Abstract][Full Text] [Related]
37. Tuberous sclerosis as an underlying basis for infantile spasm.
Yeung RS
Int Rev Neurobiol; 2002; 49():315-32. PubMed ID: 12040899
[TBL] [Abstract][Full Text] [Related]
38. Modifying genetic epilepsies - Results from studies on tuberous sclerosis complex.
Jozwiak S; Kotulska K; Wong M; Bebin M
Neuropharmacology; 2020 Apr; 166():107908. PubMed ID: 31962286
[TBL] [Abstract][Full Text] [Related]
39. Current management for epilepsy in tuberous sclerosis complex.
Curatolo P; Bombardieri R; Cerminara C
Curr Opin Neurol; 2006 Apr; 19(2):119-23. PubMed ID: 16538083
[TBL] [Abstract][Full Text] [Related]
40. DEPDC5 and NPRL3 modulate cell size, filopodial outgrowth, and localization of mTOR in neural progenitor cells and neurons.
Iffland PH; Baybis M; Barnes AE; Leventer RJ; Lockhart PJ; Crino PB
Neurobiol Dis; 2018 Jun; 114():184-193. PubMed ID: 29481864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
